Rallybio Corp - 8-K Filing
Rallybio stockholders approve merger with Avenzo Therapeutics, reverse stock split, and name change to Avenzo Therapeutics, Inc. (Items: 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Offi, 5.07 Submission of Matters to a Vote of Security Holders, 8.01 Other Events, 9.01 Financial Statements and Exhibits)
Tickers: $RLYB
Read the full article at SEC EDGAR
Part of the story Zedge, Inc. - 8-K Filing (63 articles)